Statistics
Total Visits
| Views | |
|---|---|
| Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial | 141 |
Total Visits Per Month
| February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | |
|---|---|---|---|---|---|---|---|
| Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial | 0 | 0 | 2 | 4 | 1 | 3 | 9 |
Top country views
| Views | |
|---|---|
| United States | 64 |
| Poland | 52 |
| China | 5 |
| Sweden | 4 |
| Ireland | 3 |
| Russia | 3 |
| Australia | 2 |
| France | 2 |
| Ukraine | 2 |
| Germany | 1 |
Top cities views
| Views | |
|---|---|
| Warsaw | 52 |
| Louisville | 24 |
| San Ramon | 8 |
| Boardman | 7 |
| Costa Mesa | 5 |
| Ann Arbor | 4 |
| Beijing | 4 |
| Dublin | 3 |
| San Diego | 3 |
| Ashburn | 2 |